The Burden of Cardiovascular Diseases Among US States, 1990-2016

Imagem de Miniatura
Arquivos
art_ROTH_The_Burden_of_Cardiovascular_Diseases_Among_US_States_2018.PDF (981.55 KB)
Citações na Scopus
286
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
ROTH, Gregory A.
JOHNSON, Catherine O.
ABATE, Kalkidan Hassen
ABD-ALLAH, Foad
AHMED, Muktar
ALAM, Khurshid
ALAM, Tahiya
ALVIS-GUZMAN, Nelson
ANSARI, Hossein
ARNLOV, Johan
Autor de Grupo de pesquisa
Global Burden Cardiovasc Dis Coll
Citação
JAMA CARDIOLOGY, v.3, n.5, p.375-389, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IMPORTANCE Cardiovascular disease (CVD) is the leading cause of death in the United States, but regional variation within the United States is large. Comparable and consistent state-level measures of total CVD burden and risk factors have not been produced previously. OBJECTIVE To quantify and describe levels and trends of lost health due to CVD within the United States from 1990 to 2016 as well as risk factors driving these changes. DESIGN, SETTING, AND PARTICIPANTS Using the Global Burden of Disease methodology. cardiovascular disease mortality, nonfatal health outcomes, and associated risk factors were analyzed by age group, sex, and year from 1990 to 2016 for all residents in the United States using standardized approaches for data processing and statistical modeling. Burden of disease was estimated for 10 groupings of CVD, and comparative risk analysis was performed. Data were analyzed from August 2016 to July 2017. EXPOSURES Residing in the United States. MAIN OUTCOMES AND MEASURES Cardiovascular disease disability-adjusted life-years (DALYs). RESULTS Between 1990 and 2016, age-standardized CVD DALYs for all states decreased. Several states had large rises in their relative rank ordering for total CVD DALYs among states, including Arkansas, Oklahoma, Alabama, Kentucky, Missouri, Indiana, Kansas, Alaska, and Iowa. The rate of decline varied widely across states, and CVD burden increased for a small number of states in the most recent years. Cardiovascular disease DALYs remained twice as large among men compared with women. Ischemic heart disease was the leading cause of CVD DALYs in all states, but the second most common varied by state. Trends were driven by 12 groups of risk factors, with the largest attributable CVD burden due to dietary risk exposures followed by high systolic blood pressure, high body mass index, high total cholesterol level, high fasting plasma glucose level, tobacco smoking, and low levels of physical activity. Increases in risk-deleted CVD DALY rates between 2006 and 2016 in 16 states suggest additional unmeasured risks beyond these traditional factors. CONCLUSIONS AND RELEVANCE Large disparities in total burden of CVD persist between US states despite marked improvements in CVD burden. Differences in CVD burden are largely attributable to modifiable risk exposures.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/29832
Referências
  1. Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091
  2. Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112
  3. Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474
  4. Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248
  5. Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645
  6. Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066
  7. Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938
  8. Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
  9. Ford ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065228
  10. Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMP1110421, 10.1056/NEJMp1110421]
  11. Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
  12. Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4
  13. Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
  14. Henry J Kaiser Family Foundation, STATUS OF STATE ACTI
  15. Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389
  16. Howard G, 1999, AM J MED SCI, V317, P160
  17. Kaufman HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063416
  18. LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
  19. Lewington S, 2002, LANCET, V360, P1903
  20. Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
  21. Mensah GA, 2006, J CARDIOVASC NURS, V21, P451, DOI 10.1097/00005082-200611000-00007
  22. Mersha TB, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-014-0023-x
  23. Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777
  24. Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
  25. Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423
  26. O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300
  27. Oates GR, 2017, AM J PREV MED, V52, pS31, DOI 10.1016/j.amepre.2016.09.004
  28. Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
  29. Pearson-Stuttard J, 2016, CIRCULATION, V133, P967, DOI 10.1161/CIRCULATIONAHA.115.019904
  30. Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646
  31. Rana JS, 2016, AM J PREV MED, V50, P637, DOI 10.1016/j.amepre.2015.12.009
  32. Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969
  33. Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
  34. Roth GA, 2016, J AM COLL CARDIOL, V67, P1062, DOI 10.1016/j.jacc.2015.12.046
  35. Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
  36. Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326
  37. Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231
  38. Starfield B, 2007, SOC SCI MED, V64, P1355, DOI 10.1016/j.socscimed.2006.11.027
  39. Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a
  40. Truven Health Analytics, 2000, UNITED STATES MARKET
  41. Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
  42. Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
  43. Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8
  44. Whelton PK, 2017, ACC AHA AAPA ABC ACP, DOI [10.1161/HYP.0000000000000066, DOI 10.1161/HYP.0000000000000066]
  45. Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03